Jennifer Adelsperger

4.2k citations
6 papers · 793 indexed · h-index 5
Topics
Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers)Acute Myeloid Leukemia Research (3 papers)Chronic Myeloid Leukemia Treatments (3 papers)

In The Last Decade

Jennifer Adelsperger

6 papers receiving 786 citations

Peers

Jennifer Adelsperger
Comparison fields: 5 of 57
  • Hematology 444
  • Molecular Biology 417
  • Immunology 222
  • Genetics 155
  • Oncology 101
Replace Claudiu Cotta with:
Claudiu Cotta United States
Ariel Forrai Australia
Chung Hoow Kok Australia
Aleksandra Rizo United States
Hédia Chagraoui France
Kuniko Kawaishi Japan
Jenny Klintman Sweden
Idoya Lahortiga Spain
F-X Mahon France
Maher Albitar United States
Jennifer Adelsperger relative to Claudiu Cotta United States Claudiu Cotta's profile →
Citations per field
00.5×1.5×2.4×
Claudiu Cotta · 1×
Citations per year

Countries citing papers authored by Jennifer Adelsperger

Since Specialization
Citations

This map shows the geographic impact of Jennifer Adelsperger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Adelsperger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Adelsperger more than expected).

Fields of papers citing papers by Jennifer Adelsperger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Adelsperger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Adelsperger. The network helps show where Jennifer Adelsperger may publish in the future.

Co-authorship network of co-authors of Jennifer Adelsperger

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Adelsperger. A scholar is included among the top collaborators of Jennifer Adelsperger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Adelsperger. Jennifer Adelsperger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 149
2 72
3 364
4 198
5 9
6 1

About Jennifer Adelsperger

Jennifer Adelsperger is a scholar working on Hematology, Genetics and Rheumatology, having authored 6 papers that have together received 793 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Hematology (444 citations), Genetics (155 citations) and Immunology (222 citations). Jennifer Adelsperger has collaborated with scholars based in United States, Switzerland and Sweden. Frequent co-authors include Joseph D. Growney, D. Gary Gilliland, Benjamin H. Lee, Ifor R. Williams, Jeffery L. Kutok, Doriano Fabbro, James D. Griffin, R. M. Rowan, Zhe Li and David P. Curley. Their work appears in journals such as Blood, Cancer Cell and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026